Neurocrine Biosciences has signed a definitive agreement to acquire Soleno Therapeutics for $53.00 per share in cash.The post Neurocrine to...
Zeto has received the US FDA 510(k) clearance for its New Wave electroencephalogram (EEG) system, marking its third FDA-cleared device.The...
AstraZeneca has reported positive high-level data from the EMERALD-3 Phase III trial, evaluating Imfinzi plus Imjudo, lenvatinib and TACE in...
Distalmotion has submitted a 510(k) application to the FDA seeking clearance to use the DEXTER robotic surgery system for sacrocolpopexy,...
Actinogen has treated the first participant in the OLE segment of its Phase IIb/III pivotal XanaMIA AD trial after completion...
Biocytogen has entered a strategic partnership with Sihuan Pharmaceutical to advance new therapeutics across several disease areas.The post Biocytogen and...
MediBeacon has received the CE Mark certification under the EU MDR for its TGFR monitor and reusable sensor.The post MediBeacon...
AstraZeneca has reported positive results from the efzimfotase alfa Phase III clinical trial programme for HPP, a rare metabolic bone...
Symeres has partnered with Ambagon Therapeutics on molecular glue research in colorectal cancer to target diseases considered hard to treat.The...
Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.